Cargando…
Pharmaceutical lobbying in Brazil: a missing topic in the public health research agenda
In the US, where registration of lobbyists is mandatory, the pharmaceutical industry and private health-care providers spend huge amounts of money seeking to influence health policies and government decisions. In Brazil, where lobbying lacks transparency, there is virtually no data on drug industry...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Faculdade de Saúde Pública da Universidade de São Paulo
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152825/ https://www.ncbi.nlm.nih.gov/pubmed/28099661 http://dx.doi.org/10.1590/S1518-8787.2016050006508 |